The House of Representatives voted to repeal the Community Living Assistance Services and Supports (CLASS) Act, a long-term-care insurance provision of the 2010 healthcare reform law.
Read more at: http://tinyurl.com/89gczuf
Source: Modern Healthcare
"Nobody believed that it had any real merit when it was passed,” Rep. Tom Price (R-Ga.), a physician, said prior to the vote. According to Price, the CLASS program precludes the ability of patients, families and their physicians to decide what long-term care is for seniors or anyone who needs long-term services. “It inserts the federal government in a way that makes it much more difficult for choices to be realized,” Price said. “And that's wrong.”
In a 267-159 vote—including support from 28 Democrats—House members approved a bill that Rep. Charles Boustany (R-La.), a physician, introduced a year ago. Called the Fiscal Responsibility and Retirement Security Act of 2011, the bill overturns the CLASS Act, a voluntary, public-supported long-term-care insurance program. CLASS was the subject of much debate on Capitol Hill throughout 2011, and HHS suspended the program last fall. Boustany's bill serves the purpose of preventing the program from resurfacing.
Streamlining "Brain-to-Vein" Time, Patient Selection, Imperative for Implementing CAR T for MM
March 21st 2025Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Overcoming CAR T Manufacturing Failure in LBCL
March 21st 2025Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen receptor (CAR) T-cell administration in patients with relapsed/refractory large B-cell lymphoma (LBCL).
Read More